# Dendritic Cell Based Therapy of Metastatic Breast Cancer

> **NCT00197925** · PHASE1,PHASE2 · TERMINATED · sponsor: **Herlev Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **BIOLOGICAL:** Onco-peptide loaded autologous dendritic cells

## Key facts

- **NCT ID:** NCT00197925
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** all patients recruited
- **Last updated:** 2008-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197925, "Dendritic Cell Based Therapy of Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00197925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*